The course and management of pregnancy after heart surgery with Tetralogy of Fallot (Cilinical Situation)
Abstract
Cardiovascular disease is one of the most common non-obstetric causes of maternal death. Managing these situations can be difficult for the entire mother and fetus care team . Advances in cardiac surgery has improved quality of life and cardiovascular function in patients with congenital or acquired heart defects. These diseases complicate 0.1-4% of pregnancies. Complications in the mother can occur in the form of thromboembolic events, hemorrhagic events, and heart failure. When exposed to anticoagulant therapy and other drugs prescribed to the patient to support the cardiovascular system, the fetus is at risk, conditions such as intrauterine growth retardation and hypoxia may occur.
References
Anjali Vivek Kanhere and Vivek Madhav Kanhere. Pregnancy after Cardiac Surgery // J Obstet Gynaecol India. 2016 Feb; 66(1): 10–15. Published online 2016 Feb 8. doi: 10.1007/s13224-016-0841-y.PMCID: PMC4755950/PMID: 26924901. Invited Mini Review
Royal College of Obstetricians and Gynaecologists. Why mothers die 2000–2002—the sixth report of confidential enquiries into maternal deaths in the United Kingdom. London: RCOG press; 2004. [Google Scholar]
Srivastava AP, Modi P, Sahi S, et al. Anticoagulation for pregnant patients. Ann Card Anesth. 2007; 10:95–107. doi: 10.4103/0971-9784.37934. [PubMed] [CrossRef] [Google Scholar]
Elkayam U, Bitar F. Valvular heart disease and pregnancy part II: prosthetic valves. J Am Coll Cardiol. 2005;46(3):403–410. doi: 10.1016/j.jacc.2005.02.087. [PubMed] [CrossRef] [Google] [Scholar].
European Society of Gynecology (ESG) Association for European Pediatrics Cardiology (AEPC) German Society for Gender Medicine (DGesGM) et al. ESC guidelines on the management of cardiovascular diseases during pregnancy: the task force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC) Eur Heart J. 2011; 32:3147. doi: 10.1093/eurheartj/ehr218. [PubMed] [CrossRef] [Google Scholar]
Hirsh J, Dalen JE, Deykin D et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. In: Fourth ACCP consensus conference on antithrombotic therapy. Chest. 1995; 108(suppl):231S–246S. [PubMed]
Hung L, Rahimtoola SH. Prosthetic heart valves and pregnancy clinical update. Circulation. 2003; 107:1240–1246. doi: 10.1161/01.CIR.0000060806.86686.EC. [PubMed] [CrossRef] [Google Scholar]
Castellano JM, Narayan RL, Vaishnava P, et al. Anticoagulation during pregnancy in patients with a prosthetic heart valve. Nat Rev Cardiol. 2012;9: 415-424. doi: 10.1038/nrcardio.2012.69. [PubMed] [CrossRef] [Google Scholar]
Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:e57. doi: 10.1016/j.jacc.2014.02.536. [PubMed] [CrossRef] [Google Scholar]
Starling LD. Fetal warfarin syndrome. BMJ Case Reports http://casereports.bmj.com/content/2012/bcr-2012-007344. [PMC free article] [PubMed]
Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systemic review of the literature. Arch Intern Med. 2000; 160:191–196. doi: 10.1001/archinte.160.2.191. [PubMed] [CrossRef] [Google Scholar]
Sorin C. Juverdeanu. Surgical termination of pregnancy for maternal cardiac disease: a safer option? TMJ. 2009;59(2):169–172. [Google Scholar]
Ray P, Murphy GJ. Recognition and management of maternal cardiac disease in pregnancy. Br J Anaesth. 2004; 93(3):428–439. doi: 10.1093/bja/aeh194. [PubMed][CrossRef] [Google Scholar]
Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular
Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008;118(15): e523–661. doi: 10.1161/CIRCULATIONAHA.108.190748. [PubMed] [CrossRef]
[Google Scholar].
Keywords
heart disease surgery
anticoagulants hamiləlik
ürək xəstəliyi əməliyyatı
antikoaqulyantlar беременность
хирургия порока сердцa
антикоагулянты
Most read articles by the same author(s)
- J.F. Qurbanova, A.F. Ismailova, Kh.M. Tahmazi, Covid-19 and clinical recommendations for the provision of medical assistance to women during pregnancy, childbirth and the postpartum period , Actual Questions of Modern Gynecology and Perinatology : Vol. 7 No. 3 (2020): Actual Questions of Modern Gynaecology and Perinatology